Rapid purification of recombinant dengue and West Nile virus envelope Domain III proteins by metal affinity membrane chromatography

Protein Expression and Purification

Volumn 74, Issue 1, 2010, Pages 129-137

  Tan, Lik Chern Melvin ^a   Chua, Anthony Jin Shun ^a   Goh, Li Shan Liza ^a   Pua, Shu Min ^a   Cheong, Yuen Kuen ^a   Ng, Mah Lee ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Dengue virus; Envelope Domain III; Flavivirus; Membrane chromatography; Protein purification; West Nile virus

Indexed keywords

RECOMBINANT PROTEIN; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL LINE; DENGUE; DENGUE VIRUS; ECONOMICS; ESCHERICHIA COLI; FEMALE; GENETICS; IMMUNIZATION; ISOLATION AND PURIFICATION; METHODOLOGY; MOSQUITO; MOUSE; PLASMID; TIME; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIGENS, VIRAL; CELL LINE; CHROMATOGRAPHY, AFFINITY; CULICIDAE; DENGUE; DENGUE VIRUS; ESCHERICHIA COLI; FEMALE; IMMUNIZATION; MICE; MICE, INBRED BALB C; PLASMIDS; RECOMBINANT PROTEINS; TIME FACTORS; VIRAL ENVELOPE PROTEINS; WEST NILE FEVER; WEST NILE VIRUS;

ARTHROPODA; DENGUE VIRUS; FLAVIVIRUS; MUS; WEST NILE VIRUS;

EID: 77957883952     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2010.06.015     Document Type: Article

References (41)

1. M. Alvarez, R. Rodriguez-Roche, L. Bernardo, S. Vazquez, L. Morier, D. Gonzalez, O. Castro, G. Kouri, S.B. Halstead, and M.G. Guzman Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidermic, 2001-2002 Am. J. Trop. Hyg. 75 2006 1113 1117
2. D.J. Gubler Dengue and dengue hemorrhagic fever Clin. Microbiol. Rev. 11 1998 480 496
3. S.B. Halstead Pathogenesis of dengue: challenges to molecular biology Science 239 1988 476 481
4. S.B. Halstead Dengue Lancet 370 2007 1644 1652
5. A. Wilder-Smith, and E. Schwartz Dengue in travelers N. Engl. J. Med. 353 2005 924 932
6. D.J. Gubler Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century Trends. Microbiol. 10 2002 100 103
7. R.S. Lanciotti, J.T. Roehrig, V. Deubel, J. Smith, M. Parker, K. Steele, B. Crise, K.E. Volpe, M.B. Crabtree, J.H. Scherret, R.A. Hall, J.S. MacKenzie, C.B. Cropp, B. Panigrahy, E. Ostlund, B. Schmitt, M. Malkinson, C. Banet, J. Weissman, N. Komar, H.M. Savage, W. Stone, T. McNamara, and D.J. Gubler Origin of the West Nile virus responsible for an outbreak of encephalitis in the Northeastern United States Science 286 1999 2333 2337
8. Centers for Disease Control and Prevention (CDC), 2009. Updated as of 8th December 2009, .
9. K. Clyde, J.L. Kyle, and E. Harris Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis J. Virol. 80 2006 11418 11431
10. J.S. Mackenzie, D.J. Gubler, and L.R. Petersen Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses Nat. Med. 10 2004 S98 S109
11. S. Mukhopadhyay, R.J. Kuhn, and M.G. Rossmann A structural perspective of the flavivirus life cycle Nat. Rev. Microbiol. 3 2005 13 22
12. F.A. Rey, F.X. Heinz, C. Mandl, C. Kunz, and S.C. Harrison The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution Nature 375 1995 291 298
13. S. Bhardwaj, M. Holbrook, R.E. Shope, A.D.T. Barrett, and S.J. Watowich Biophysical characterization and vector-specific antagonist activity of domain III of tick-borne flavivirus envelope protein J. Virol. 75 2001 4002 4007
14. J.F.L. Chin, J.J.H. Chu, and M.L. Ng The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry Microb. Inf. 9 2007 1 6
15. J.J.H. Chu, R. Rajamanonmani, J. Li, R. Bhuvanakantham, J. Lescar, and M.L. Ng Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein J. Gen. Virol. 86 2005 405 412
16. Z.S. Zhang, Y.S. Yan, Y.W. Weng, H.L. Huang, S.Q. Li, S. He, and J.M. Zhang High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice J. Virol. Methods 143 2007 125 131
17. W.D. Crill, and J.T. Roehrig Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero Cells J. Virol. 75 2001 7769 7773
18. G.D. Gromowski, and A.D.T. Barrett Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus Virology 366 2007 349 360
19. O. Lisova, F. Hardy, V. Petit, and H. Bedouelle Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus J. Gen. Virol. 88 2007 2387 2397
20. R. Rajamanonmani, C. Nkenfou, P. Clancy, Y.H. Yau, S.G. Shochat, S. Sukupolvi-Petty, W. Schul, M.S. Diamond, S.G. Vasudevan, and J. Lescar On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes J. Gen. Virol. 90 2009 799 809
21. S. Chen, M. Yu, T. Jiang, Y. Deng, C. Qin, and E. Qin Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein DNA Cell. Biol. 26 2007 361 367
22. B. Etemed, G. Batra, R. Raut, S. Dahiya, S. Khanam, S. Swaminathan, and N. Khanna An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes Am. J. Trop. Med. Hyg. 79 2008 353 363
23. P. Pattnaik, J.P. Babu, S.K. Verma, V. Tak, and P.V.L. Rao Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 846 2007 184 194
24. N.K. Tripathi, A. Shrivastva, P. Pattnaik, M. Prida, P.K. Dash, A.M. Jana, and P.V.L. Rao Production, purification and characterization of recombinant dengue multiepitope protein Biotechnol. Appl. Biochem. 46 2007 105 113
25. N.K. Tripathi, J.P. Babu, A. Shrivastva, M. Parida, A.M. Jana, and P.V.L. Rao Production and characterization of recombinant dengue virus type 4 serotype envelope domain III protein J. Biotechnol. 134 2008 278 286
26. R. Ghosh Protein separation using membrane chromatography: opportunities and challenges J. chromatogr. A. 952 2002 13 27
27. C. Charcosset Membrane process in biotechnology: an overview Biotechnol. Adv. 24 2006 482 492
28. G. Shi, J. Shao, G. Jiang, Q. Wang, Y. Lu, J. Liu, and J. Liu Membrane chromatographic method for the rapid purification of vetellogenin from fish plasma J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 785 2003 361 368
29. K.H. Gebauer, J. Thommes, and M.R. Kula Plasma protein fractionation with advanced membrane adsorbents Biotechnol. Bioeng. 54 1997 181 189
30. H.L. Knudsen, R.L. Fahrner, Y. Xu, L.A. Norling, and G.S. Blank Membrane ion-exchange chromatography for process-scale antibody purification J. Chromatogr. A. 907 2001 145 154
31. R.R. Deshmukh, T.N. Warner, F. Hutchison, M. Murphy, W.E. Leitch II, P. De Leon, G.S. Srivatsa, D.L. Cole, and Y.S. Sanghvi Large-scale purification of antisense oligonucleotides by high-performance membrane adsorber chromatography J. Chromatogr. A. 890 2000 179 192
32. A. Karger, B. Bettin, H. Granzow, and T.C. Mettenleiter Simple and rapid purification of alphaherpesviruses by chromatography on a cation exchange membrane J. Virol. Methods. 70 1998 219 224
33. C. Boi Membrane adsorbers as purification tools for monoclonal antibody purification J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 848 2007 19 27
34. W. Demmer, and D. Nussbaumer Large-scale membrane adsorbers J. Chromatogr. A. 852 1999 73 81
35. K. Plate, S. Beutel, H. Buchholz, W. Demmer, S. Fisher-Fruhholz, O. Reif, R. Ulber, and T. Scheper Isolation of bovine lactoferrin, lactoperoxidase and enzymatically prepared lactoferricin from proteolytic digestion of bovine lactoferrin using adsorptive membrane chromatography J. Chromatogr. A. 1117 2006 81 86
36. J.P. Babu, P. Pattnaik, N. Gupta, A. Shrivastava, M. Khan, and P.V.L. Rao Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice Vaccine 26 2008 4655 4663
37. W. Saejung, K. Fujiyama, T. Takasaki, M. Ito, K. Hori, P. Malasit, Y. Watanabe, I. Kurane, and T. Seki Production of dengue 2 envelope domain III in plant using TMV-based vector system Vaccine 25 2007 6646 6654
38. J.X. Zhou, and T. Tressel Basic concepts in Q membrane chromatography for large-scale antibody production Biotechnol. Prog. 22 2006 341 349
39. M.G. Guzman, L. Hermida, L. Bernardo, R. Ramirez, and G. Guillen Domain III of the envelope protein as a dengue vaccine target Exp. Rev. Vaccines 9 2010 137 147
40. M.R. Holbrook, R.E. Shope, and A.D.T. Barrett Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses J. Clin. Microb. 42 2004 4101 4110
41. D. Ludolfs, S. Schilling, J. Altenschmidt, and H. Schmitz Serological differentiation of infections with dengue virus serotypes 1 to 4 by using recombinant antigens J. Clin. Microb. 40 2002 4317 4320